Stay updated on KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial

Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-11T22:21:33.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previous study record content with an access-denied screen.
    Difference
    19%
    Check dated 2026-09-20T19:56:28.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The status of the study shifted from Active, not recruiting to Completed as of 2026-09-04, and the prior recruiting indicator was removed on 2026-07-30. This update indicates that enrollment and study activities have concluded.
    Difference
    0.1%
    Check dated 2026-09-06T16:58:54.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A funding/identifier line for 2023 U.S. NIH Grant/Contract was added, and the page revision was updated from v3.6.5 to v3.6.6.
    Difference
    0.0%
    Check dated 2026-08-30T15:18:29.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision: v3.6.5 is now displayed, indicating an update to the study record. This appears to be an administrative maintenance update rather than a substantive change to the study data or eligibility.
    Difference
    0.0%
    Check dated 2026-08-09T09:19:16.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    A new Hangzhou site in Zhejiang, China (310009) with status Completed was added on 2026-07-30, and an existing Hangzhou site (310016) with status Active, not recruiting was removed on 2026-07-14. These changes update the study's site roster and reflect shifting enrollment activity.
    Difference
    0.2%
    Check dated 2026-08-01T23:09:46.000Z thumbnail image

Stay in the know with updates to KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.